5Gold EB. Epiderniology and risk facfors in pancreatic Cancet[J]. Surg Clin North Am, 1995,75(5) :819-843.
6Warshaw AL, Castillo C. Pancreatic carcinoma. New Engl J Med, 1993,326 ( 7 ) :455 - 465.
7American gastroenterological association medical position statement : epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology, 1999,117 ( 6 ) : 1463 - 1484.
8CalculliL, CasadeiR, DiaconoD, et al. Role of spiral computerized tomography in the staging ofpancreatic carcinoma. Radiol Med, 1998,95:344 - 348.
9Athlin L, Blind PJ, Briksson S. The value of routine biochemical tests in discriminating between malignant and benign pancreatic tumor. HPB - Surg, 1991,4 ( 1 ) : 147 - 15.
10Bosch VRP, Vaneijck CHJ, Mulder PGH,et al. Serum A19 - 9 determination in the management of pancreatic cancer. Hepato - Gastroenterology, 1996,43 ( 20 ) : 710 - 713.
